Da Briumvi a Yselty. 17 nuovi farmaci in commercio


Arrivano nuove specialità medicinali: Briumvi, Casarenel, Ibuprofene Gen Orph, Yselty e 12 nuovi farmaci equivalenti

enpaf farmacisti

Nelle farmacie e parafarmacie arrivano nuove specialità medicinali: Briumvi, Casarenel, Ibuprofene Gen Orph, Yselty e 12 nuovi farmaci equivalenti.

Nuove specialità medicinali
BRIUMVI 1 flaconcino EV 6 ml 25 mg/ml ublituximab
NEURAXPHARM AIC:050698012 5.614,67€ Cnn/OSP in commercio dal:06/11/2024

CASARENEL gel tubo 45 g 1 mg/g + 25 mg/g benzoilperossido/adapalene
LABORATOIRES MEDGEN AIC:050410024 36,75€ C /RR in commercio dal:11/11/2024

IBUPROFENE GEN ORPH 4 fiale EV 2 ml 5 mg/ml ibuprofene
GEN.ORPH AIC:051114015 760,36€ Cnn/OSP in commercio dal:08/11/2024

YSELTY 28 cpr riv 100 mg linzagolix sale di colina
THERAMEX AIC:050222013 172,79€ A /RNRL in commercio dal:11/11/2024

YSELTY 28 cpr riv 200 mg linzagolix sale di colina
THERAMEX AIC:050222025 172,79€ A /RNRL in commercio dal:11/11/2024

Nuovi farmaci equivalenti
ATORVASTATINA DOC GENERICS 30 cpr riv 20 mg atorvastatina calcio triidrato
DOC AIC:048247023 7,96€ A /RR in commercio dal:08/11/2024

LACOSAMIDE DR. REDDY’S 1 flaconcino INFUS EV 20 ml 10 mg/ml lacosamide
DR.REDDY’S AIC:051051011 79,20€ C /RR in commercio dal:04/11/2024

LEVETIRACETAM ALTER 60 cpr riv 250 mg levetiracetam
LABORATORI ALTER AIC:040534125 18,84€ A /RR in commercio dal:06/11/2024

ONDANSETRON DOC 6 cpr orodispers 4 mg ondansetrone
DOC AIC:050805011 23,89€ A /RR in commercio dal:12/11/2024

ONDANSETRON DOC 6 cpr orodispers 8 mg ondansetrone
DOC AIC:050805023 38,69€ A /RR in commercio dal:12/11/2024

OXALIPLATINO AUROBINDO 1 flaconcino EV 200 mg 40 ml 5 mg/ml oxaliplatino
EUGIA PHARMA AIC:050405036 570,12€ H /OSP in commercio dal:08/11/2024

RASAGILINA AUROBINDO 28 cpr 1 mg rasagilina tartrato
AUROBINDO AIC:043934037 57,99€ A /RR in commercio dal:12/11/2024

RIVAROXABAN DOC 28 cpr riv 20 mg rivaroxaban
DOC AIC:049651058 29,02€ A /RR/RRL in commercio dal:12/11/2024

RIVAROXABAN DOC 30 cpr riv 10 mg rivaroxaban
DOC AIC:049651033 31,10€ A /RRL in commercio dal:12/11/2024

RIVAROXABAN DOC 42 cpr riv 15 mg rivaroxaban
DOC AIC:049651045 43,54€ A /RR/RRL in commercio dal:12/11/2024

TADALAFIL TEVA 28 cpr riv 5 mg tadalafil
TEVA AIC:045617293 52,00€ C /RR in commercio dal:06/11/2024

TADALAFIL TEVA 4 cpr riv 20 mg tadalafil
TEVA AIC:045617533 31,00€ C /RR in commercio dal:11/11/2024